Smoking Cessation in Cancer Treatment
An Intervention Study of a Smoking Cessation Program Offered to Newly Diagnosed Cancer Patients at Their First Consultation for Treatment at an Oncological Hospital Department
Sponsor: Helse Møre og Romsdal HF
This NA trial investigates Motivation and Smoking Cessation and is currently ongoing. Helse Møre og Romsdal HF leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Enrolling By Invitation NA
-
Sep 2019 — Jan 2021 [monthly]
Enrolling By Invitation NA
▶ Show 2 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Enrolling By Invitation NA
-
Nov 2017 — Jun 2018 [monthly]
Enrolling By Invitation NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Helse Møre og Romsdal HF
- Helse Stavanger HF
- Norwegian Cancer Society
- Norwegian Institute of Public Health
- Oslo University Hospital
- Sorlandet Hospital HF
- St. Olavs Hospital
- University Hospital of North Norway
For direct contact, visit the study record on ClinicalTrials.gov .